Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial
- 28 April 2000
- journal article
- editorial
- Published by Elsevier
- Vol. 10 (3) , 165-169
- https://doi.org/10.1016/s0924-977x(00)00065-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Pindolol does not act only on 5-HT 1A receptors in augmenting antidepressant activity in the mouse forced swimming testPsychopharmacology, 1998
- Antagonist properties of (−)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brainBritish Journal of Pharmacology, 1998
- Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trialAmerican Journal of Psychiatry, 1997
- Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorderInternational Clinical Psychopharmacology, 1996
- Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major DepressionJournal of Clinical Psychopharmacology, 1995
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Limited therapeutic effect of addition of buspirone in fluvoxamine- refractory obsessive-compulsive disorderAmerican Journal of Psychiatry, 1993
- 5-Hydroxytryptamine1A Receptor Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1991
- The Epidemiology of Obsessive-Compulsive Disorder in Five US CommunitiesArchives of General Psychiatry, 1988
- Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist ActivityNew England Journal of Medicine, 1983